Xact Kapitalforvaltning’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-7,600
Closed -$209K 1569
2018
Q2
$209K Buy
+7,600
New +$209K ﹤0.01% 1534